[Evidence-based Therapy: A Rational Approach to Eradication].
作者信息
Kwon Yong Hwan
出版信息
Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):81-83. doi: 10.7704/kjhugr.2023.0027. Epub 2023 Jun 12.
Abstract
摘要
相似文献
1
[Evidence-based Therapy: A Rational Approach to Eradication].[循证治疗：根除的合理方法]
Korean J Helicobacter Up Gastrointest Res. 2023 Jun;23(2):81-83. doi: 10.7704/kjhugr.2023.0027. Epub 2023 Jun 12.
2
treatment in Turkey: Current status and rational treatment options.土耳其的治疗：现状与合理的治疗选择。
North Clin Istanb. 2019 Jul 11;7(1):87-94. doi: 10.14744/nci.2019.62558. eCollection 2020.
3
Eradication of Helicobacter pylori: therapies and clinical implications.幽门螺杆菌的根除：治疗方法及临床意义
Postgrad Med J. 1992 Jul;68(801):549-57. doi: 10.1136/pgmj.68.801.549.
4
Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.韩国幽门螺杆菌再感染的根除率：一项回顾性研究。
J Gastroenterol Hepatol. 2019 Oct;34(10):1696-1702. doi: 10.1111/jgh.14639. Epub 2019 Mar 14.
5
The impact of probiotics on gut microbiota in the eradication of Helicobacter pylori infection: a systematic review.益生菌对根除幽门螺杆菌感染中肠道微生物群的影响：系统评价。
Eur Rev Med Pharmacol Sci. 2023 Jul;27(14):6736-6743. doi: 10.26355/eurrev_202307_33144.
6
Tailored eradication strategy concomitant therapy for eradication treatment in Korean patients.个体化根除策略联合治疗用于韩国患者的根除治疗。
World J Gastroenterol. 2021 Aug 21;27(31):5247-5258. doi: 10.3748/wjg.v27.i31.5247.
7
Comparison of proton pump inhibitor-based triple therapy with losec and the generic drug, Omepradex, for efficacy of Helicobacter pylori eradication.基于质子泵抑制剂的三联疗法（使用洛赛克和通用药物奥美拉唑）对根除幽门螺杆菌疗效的比较。
Dig Dis Sci. 2005 Apr;50(4):623-5. doi: 10.1007/s10620-005-2546-4.
8
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.雷尼替丁枸橼酸铋或基于奥美拉唑的三联疗法用于根除幽门螺杆菌感染的非溃疡性消化不良患者的幽门螺杆菌。
Dig Liver Dis. 2001 Mar;33(2):125-30. doi: 10.1016/s1590-8658(01)80066-9.
9
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.幽门螺杆菌阳性人群消化性溃疡疾病的根除治疗。
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5.
10
Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection.铋剂四联疗法作为一线方案根除幽门螺杆菌感染的疗效。
Helicobacter. 2021 Jun;26(3):e12792. doi: 10.1111/hel.12792. Epub 2021 Mar 1.
本文引用的文献
1
Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Infection: A Multicenter Randomized Controlled Trial.铋剂四联疗法与甲硝唑强化三联疗法作为克拉霉素耐药感染一线治疗的比较：一项多中心随机对照试验。
Gut Liver. 2022 Sep 15;16(5):697-705. doi: 10.5009/gnl210365. Epub 2022 Feb 11.
2
Evidence-Based Guidelines for the Treatment of Infection in Korea 2020.2020 年韩国感染治疗循证指南。
Gut Liver. 2021 Mar 15;15(2):168-195. doi: 10.5009/gnl20288.
3
Dual Clarithromycin and Metronidazole Resistance Is the Main Cause of Failure in Ultimate Helicobacter pylori Eradication.双重克拉霉素和甲硝唑耐药是终极幽门螺杆菌根除失败的主要原因。
Dig Dis. 2021;39(5):451-461. doi: 10.1159/000514278. Epub 2021 Jan 11.
4
Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance.基于与克拉霉素耐药相关的23S核糖体RNA点突变测序的根除治疗
J Clin Med. 2019 Dec 25;9(1):54. doi: 10.3390/jcm9010054.
5
Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018.韩国 2003 年至 2018 年幽门螺杆菌的初级和次级抗生素耐药性。
Helicobacter. 2019 Dec;24(6):e12660. doi: 10.1111/hel.12660. Epub 2019 Sep 11.
6
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.韩国全国范围内幽门螺杆菌抗生素耐药性的绘图：一项前瞻性多中心研究。
Helicobacter. 2019 Aug;24(4):e12592. doi: 10.1111/hel.12592. Epub 2019 May 20.
7
Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study.基于克拉霉素耐药性和既往抗生素暴露情况制定的个体化治疗方案对幽门螺杆菌根除的疗效：一项单中心前瞻性初步研究。
Helicobacter. 2019 Aug;24(4):e12585. doi: 10.1111/hel.12585. Epub 2019 Apr 10.
8
An Economic Modeling Study of Eradication: Comparison of Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction and Empirical Treatment.消除策略的经济模型研究：基于双重引物寡核苷酸的多重聚合酶链反应与经验性治疗的比较。
Gut Liver. 2018 Nov 15;12(6):648-654. doi: 10.5009/gnl18079.
9
Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.基于导致克拉霉素耐药的 23S 核糖体 RNA 点突变的存在，为韩国患者量身定制的幽门螺杆菌根除策略的成本效益。
J Gastroenterol Hepatol. 2019 Apr;34(4):700-706. doi: 10.1111/jgh.14383. Epub 2018 Aug 2.
10
Dual-priming oligonucleotide-based multiplex PCR using tissue samples in rapid urease test in the detection of Helicobacter pylori infection.基于双引物寡核苷酸的多重聚合酶链反应在快速尿素酶试验中使用组织样本检测幽门螺杆菌感染
World J Gastroenterol. 2014 Jun 7;20(21):6547-53. doi: 10.3748/wjg.v20.i21.6547.
Zotero 插件